Skip to main content
. 2011 Jun 17;6(6):e21129. doi: 10.1371/journal.pone.0021129

Figure 2. Assessment of ESO expression in BC tumors from ESO Ab+ patients.

Figure 2

ESO expression in cryopreserved BC tumors from ESO Ab+ patients was assessed by semi-quantitative PCR (A) and qPCR (B) using specific primers and ESO+ (SK-MEL-37, Me252) and ESO (NA8, SK-MEL-23, Me290) tumor cell lines as internal controls.